India SEZ exports rise 11.8%
Analysis based on 6 articles · First reported Aug 04, 2026 · Last updated Aug 04, 2026
The reported growth in SEZ and pharmaceutical exports signals continued strength in India's export sector, which could support the India — Indian rupee and boost investor sentiment in export-oriented industries. The operationalization of multiple free trade agreements is expected to enhance market access and reduce trade barriers, potentially improving the competitiveness of Indian exporters and positively impacting trade-related sectors.
On August 4, 2026, the Indian government reported that exports from Special Economic Zones (SEZs) rose 11.8% year-on-year to Rs 16,36,192 crore ($185.28 billion) in fiscal 2025-26, up from Rs 14,63,669 crore ($173.07 billion) in 2024-25. The data was presented by Minister of State for Commerce and Industry Jitin Prasada in a written reply to the India — Lok Sabha. India — Gujarat led with Rs 4,05,595 crore in SEZ exports, followed by India — Karnataka, India — Maharashtra, and India — Tamil Nadu. The government also highlighted that pharmaceutical exports increased from $15.43 billion in 2014-15 to $31.12 billion in 2025-26, a CAGR of about 6.6%, with India — Maharashtra contributing about 19% of shipments. Additionally, India has finalized free trade agreements with the UAE, Australia, the UK, Oman, New Zealand, and the EFTA bloc, and is monitoring their utilization through Certificates of Origin. Since the India-UAE pact took effect in May 2022, 4.45 lakh certificates have been issued; 2.73 lakh under the Australia pact since December 2022; and 783 under the India-Oman pact since June 2026.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard